Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reliability and Influence on Decision Making of fully-automated vs. semi-automated Software Packages for Procedural Planning in TAVI.

Scientific reports·2020
Same author

A successful minimally invasive mitral valve repair following delayed device embolization in a patient with Pascal device implantation.

Turk gogus kalp damar cerrahisi dergisi·2020
Same author

Insights on Embolic Protection, Repositioning, and Stroke: A Subanalysis of the RESPOND Study.

Journal of interventional cardiology·2020
Same author

Characteristics of Contemporary Randomized Clinical Trials and Their Association With the Trial Funding Source in Invasive Cardiovascular Interventions.

JAMA internal medicine·2020
Same author

Bacterial biofilms in infective endocarditis: an in vitro model to investigate emerging technologies of antimicrobial cardiovascular device coatings.

Clinical research in cardiology : official journal of the German Cardiac Society·2020
Same author

Minimally invasive surgical aortic valve replacement through a right anterolateral thoracotomy.

Multimedia manual of cardiothoracic surgery : MMCTS·2020
Same journal

Epidemiology and determinants of cardiovascular disease in Indigenous populations.

Nature reviews. Cardiology·2026
Same journal

The origin of clinical left ventricular ejection fraction measurement.

Nature reviews. Cardiology·2026
Same journal

Inclusive cardiovascular care for sexual and gender minority populations.

Nature reviews. Cardiology·2026
Same journal

Modular cardiac microtissues for interrogating cell-type contributions.

Nature reviews. Cardiology·2026
Same journal

Sleep and exercise can limit clonal haematopoiesis clone expansion and reduce associated atherosclerosis.

Nature reviews. Cardiology·2026
Same journal

Epigenetic regulation in atherosclerosis and its therapeutic potential.

Nature reviews. Cardiology·2026
See all related articles

Related Experiment Video

Updated: May 26, 2026

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
08:12

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels

Published on: May 26, 2023

Valvular disease in 2011: Breakthrough for intervention?

Volkmar Falk1

  • 1Division of Cardiovascular Surgery, University of Zurich, Rämistrasse 100, Zurich CH-8091, Switzerland. volkmar.falk@usz.ch

Nature Reviews. Cardiology
|December 21, 2011
PubMed
Summary
This summary is machine-generated.

Transcatheter valve interventions proved noninferior to surgery for severe aortic stenosis and mitral insufficiency in 2011. However, both trials revealed limitations of these minimally invasive transcatheter valve procedures.

Related Experiment Videos

Last Updated: May 26, 2026

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
08:12

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels

Published on: May 26, 2023

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Medical Technology Evaluation

Background:

  • Transcatheter valve interventions emerged as an alternative to traditional surgery.
  • Severe aortic stenosis and mitral insufficiency pose significant clinical challenges.
  • Prior studies evaluated the efficacy of transcatheter approaches in specific patient groups.

Purpose of the Study:

  • To compare the outcomes of transcatheter interventions versus surgical procedures for aortic stenosis and mitral insufficiency.
  • To assess the noninferiority of transcatheter valve repair and replacement against conventional surgery.
  • To identify and analyze the limitations associated with transcatheter valve interventions.

Main Methods:

  • Analysis of data from the PARTNER-A trial for aortic stenosis.
  • Analysis of data from the EVEREST II trial for mitral insufficiency.
  • Review of concurrent registry data on transcatheter valve interventions.

Main Results:

  • The PARTNER-A trial demonstrated noninferiority of transcatheter aortic valve replacement (TAVR) compared to surgery for high-risk patients.
  • The EVEREST II trial showed noninferiority of transcatheter mitral valve repair compared to surgery.
  • Both trials identified specific limitations and areas for improvement in transcatheter valve procedures.

Conclusions:

  • Transcatheter interventions achieved noninferiority for selected primary endpoints in severe aortic stenosis and mitral insufficiency.
  • Despite noninferiority, limitations in transcatheter valve technology and application were evident.
  • Further research and technological advancements are needed to overcome identified challenges in transcatheter valve interventions.